Cargando…
Predictive ADMET : Integrated Approaches in Drug Discovery and Development.
By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Featuring case studies and lessons learned from real drug discovery a...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken :
Wiley,
2014.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mi 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn871224300 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 140301s2014 xx ob 001 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d OCLCQ |d IDEBK |d CDX |d RECBK |d COO |d OCLCO |d OCLCQ |d OCLCO |d E7B |d OCLCQ |d ZCU |d MERUC |d OCLCQ |d DKC |d OCLCQ |d UKAHL |d OCLCQ |d OCLCO |d OCLCQ |d OCLCL | ||
| 020 | |a 9781118783306 | ||
| 020 | |a 1118783301 | ||
| 020 | |a 9781118783344 |q (electronic bk.) | ||
| 020 | |a 1118783344 |q (electronic bk.) | ||
| 020 | |a 9781118783405 |q (electronic bk.) | ||
| 020 | |a 1118783409 |q (electronic bk.) | ||
| 020 | |a 9781118783269 |q (electronic bk.) | ||
| 020 | |a 1118783263 |q (electronic bk.) | ||
| 020 | |a 9781118299920 |q (cloth) | ||
| 020 | |a 1118299922 |q (cloth) | ||
| 020 | |a 9781306473163 |q (MyiLibrary) | ||
| 020 | |a 1306473160 |q (MyiLibrary) | ||
| 035 | |a (OCoLC)871224300 | ||
| 050 | 4 | |a RM103 .W384 2014 | |
| 082 | 0 | 4 | |a 615 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Wang, Jianling. | |
| 245 | 1 | 0 | |a Predictive ADMET : |b Integrated Approaches in Drug Discovery and Development. |
| 260 | |a Hoboken : |b Wiley, |c 2014. | ||
| 300 | |a 1 online resource (624 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Predictive ADMET; Contents; Preface; Contributors; I Introduction to the current scientific, clinical, and social environment of drug discovery and development; 1 Current Social, Clinical, and Scientific Environment of Pharmaceutical R & D; 1.1 THE CHANGING LANDSCAPE OF EPIDEMIOLOGY AND MEDICAL CARE; 1.2 COST OF DRUG DEVELOPMENT; 1.2.1 Decline in Industry Productivity; 1.2.2 Rise in Safety Issues; 1.2.3 Increasing Regulatory Requirements; 1.3 THE NEW PARADIGM OF ADMEPK ASSESSMENT; 1.3.1 Recent Advancement of ADMEPK Assessment of Drug Candidates in Discovery and Development. | |
| 505 | 8 | |a 1.3.2 New Challenges and Emerging Fields of ADMEPK Development1.4 INCREASED SAFETY EXPECTATIONS; 1.4.1 Early Awareness of Safety Hazards; 1.4.2 Logistics for In Vitro Safety Profiling; 1.4.3 Relevance and Confidence in Profiling Data; 1.5 TRANSLATIONAL VALUE OF IN VITRO PROFILING DATA; 1.6 SUMMARY; References; 2 Polypharmacology and Adverse Bioactivity Profiles Predict Potential Toxicity and Drug-related ADRs; 2.1 INTRODUCTION; 2.2 IN VITRO ADMET PROFILING; 2.3 COMPUTATIONAL METHODS PREDICTING ADMET PROPERTIES; 2.3.1 QSAR, QSPR, and Descriptor-based Methods. | |
| 505 | 8 | |a 2.3.2 Molecular Interaction- and Shape-based Approaches2.3.3 Docking; 2.4 OUTLOOK; Acknowledgments; References; II Intelligent integration and extrapolation of ADMET data; 3 ADMET Diagnosis Models; 3.1 Introduction; 3.2 Solubility Diagnosis; 3.2.1 Lipophilicity and Maximum Solubility Concept; 3.2.2 Estimating the Impact of the Solid State in the Absence of Crystalline Material; 3.2.3 When Is the Maximal Effect of Ionization Reached?; 3.2.4 The Solubility Diagnosis Matrix; 3.2.5 Diagnosis Examples (Molecules in Table); 3.3 Diagnosing Permeability. | |
| 505 | 8 | |a 3.3.1 LogP, PSA, Absorption Model, and Polarity-Lipophilicity Line (PLL)3.3.2 The Permeability Diagnosis Matrix (see Table); 3.3.3 Diagnosis Examples (Molecules in Table); 3.4 General Strategy to Apply Adme Diagnosis Models; 3.5 Concluding Remarks; References; 4 PATH (Probe ADME and Test Hypotheses): A Useful Approach Enabling Hypothesis-driven ADME Optimization; 4.1 Introduction; 4.2 Assumptions and Limitations; 4.2.1 In vitro; 4.2.2 In vivo; 4.3 Clearance IVIVC; 4.3.1 Establishing a Baseline for Clearance Correlation Analysis; 4.3.2 Clearance IVIVC Zones. | |
| 505 | 8 | |a 4.3.3 Trends, Hypotheses, and Strategies for Clearance Interrogation by Zone4.4 Oral Bioavailability (%F) IVIVC; 4.4.1 Establishing a Baseline for %F Correlation Analysis; 4.4.2 %F IVIVC Zones; 4.4.3 Trends, Hypotheses, and Strategies for %F Interrogation by Zone; 4.5 Payoffs for Intelligent Data Integration in Early Drug Discovery; References; 5 PK-MATRIX-A Permeability: Intrinsic Clearance System for Prediction, Classification, and Profiling of Pharmacokinetics and Drug-Drug Interactions; 5.1 INTRODUCTION; 5.2 SETTING UP THE PK-MATRIX; 5.3 PK-MATRIX DISTRIBUTION/CLASSIFICATION OF DRUGS. | |
| 500 | |a 5.3.1 Pe versus Hepatic Metabolic CLint. | ||
| 520 | |a By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Featuring case studies and lessons learned from real drug discovery and development, the text: helps users diagnose ADMET problems; presents appropriate recommendations; introduces the current clinical practice for drug discovery and development; and consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET dat. | ||
| 588 | 0 | |a Print version record. | |
| 504 | |a Includes bibliographical references and index. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Drug development |x Methodology. | |
| 650 | 6 | |a Médicaments |x Développement |x Méthodologie. | |
| 700 | 1 | |a Urban, Laszlo. | |
| 758 | |i has work: |a Predictive ADMET (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFtKjDBMx4c8CmGK8HCpHd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Wang, Jianling. |t Predictive ADMET : Integrated Approaches in Drug Discovery and Development. |d Hoboken : Wiley, ©2014 |z 9781118299920 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1638089 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH26202856 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH26152123 | ||
| 938 | |a Coutts Information Services |b COUT |n 27593096 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL1638089 | ||
| 938 | |a ebrary |b EBRY |n ebr10842305 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis27593096 | ||
| 938 | |a Recorded Books, LLC |b RECE |n rbeEB00258210 | ||
| 994 | |a 92 |b IZTAP | ||